Diabetes endothelial keratoplasty study: impact of diabetes on corneal transplant success and cell loss
Ended Cooperative Agreement Awarded Last action
- Award ID
- UG1EY030030
- Recipient
-
Jaeb Center For Health Research Foundation, Inc. UEI RRCZRDT5DHP1
- Awarding agency
-
National Eye Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,700,024
Award facts
- Assistance listing
- 93.867 Vision Research
- Completion date
- Funding
-
- $9,868,730.00 Federal
- $831,294.00 Non-federal
- Place of performance
- Tampa Palms, FL 33647, USA
Award details come from USAspending.gov.
Description
- Abstract
- This proposal addresses a significant public health question: does diabetes, the 3RD leading cause of death in the united states (US), impact suitability of donor corneal tissue for transplantation? This question takes on increasing urgency as recent eye bank data suggests donors with diabetes now comprise about 30-35% of the cornea donor pool, a 50-72% increase in just over a decade. The impact of diabetes on keratoplasty outcomes remains unknown, with conflicting evidence from secondary or retrospective analyses of multiple clinical studies. Previous large clinical studies did not show a diabetic donor effect on penetrating keratoplasty (PKP) and descemet membrane endothelial keratoplasty (DMEK) graft success, yet our recent cornea preservation time study (CPTS) found the diabetic donor adversely affected graft outcomes following descemet stripping automated endothelial keratoplasty (DSAEK). Although current standard of care is to use diabetic donor corneas for all types of keratoplasties, some eye banks and surgeons are increasingly avoiding them for DMEK. As both the diabetic donor population and DMEK demand increases, a definitive superiority study evaluating effect of donor diabetes status on graft outcomes will allay and/or define these concerns. The diabetes endothelial keratoplasty study (DEKS) will address these important questions through a prospective masked clinical trial enrolling 1420 participant-eyes at 30 clinical sites and 15 eye banks across the US. The DEKS will determine if the 3-year graft success rate following DMEK performed with corneas from donors without diabetes is superior to the graft success rate with corneas from donors with diabetes. IT will also determine if the 3-year central endothelial cell loss (ECL) after DMEK with corneas from donors without diabetes is less than the central ECL when corneas from donors with diabetes are used. Lastly, the DEKS will explore the relationship of donor diabetes severity, as measured by eye bank-determined diabetes risk categorization scores, post- mortem HBA1C, and skin advanced glycation endproducts and oxidation markers, with DMEK graft outcomes 3 years postoperatively in corneas from diabetic donors. The DEKS could have a major impact on the targeted use of corneas from an increasing number of donors with diabetes with a range of disease severity in a donor pool that must continue to expand to meet the clinical demands of an aging population and DMEK growth.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $675,389 | $0 | |
| Amendment | $675,389 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $443,042 | $0 | |
| Amendment | $443,042 | $0 | |
| Amendment | $474,810 | $0 | |
| Amendment | $1,608,633 | $0 | |
| Amendment | $1,608,633 | $0 | |
| Amendment | $1,138,602 | $0 | |
| Amendment | $1,138,602 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $831,294 | $0 | |
| Original award | $831,294 | $831,294 |
Show all 18
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Subrecipient not on record | $31,196 | |
| Subrecipient not on record | $36,003 | |
| Eye Centers Of Louisville PSC | $37,345 | |
| Massachusetts Eye And Ear Infirmary | $31,787 | |
| The University Of Chicago | $31,160 | |
| Subrecipient not on record | $30,624 | |
| Case Western Reserve University | $30,075 | |
| Baylor College Of Medicine | $31,888 | |
| University Of Miami | $31,759 | |
| Subrecipient not on record | $31,339 | |
| Chicago Cornea Consultants, LTD. | $31,130 | |
| Indiana Lions Eye Bank Inc. | $38,918 | |
| Subrecipient not on record | $30,404 | |
| Subrecipient not on record | $30,404 | |
| Minnesota Eye Consultants Pa | $31,911 | |
| Visiongift | $30,547 |
Show all 16
Quick answers
Who received award UG1EY030030?
UG1EY030030 was awarded to Jaeb Center For Health Research Foundation, Inc. by National Eye Institute (National Institutes of Health) on May 1, 2021.
How much is award UG1EY030030 worth?
$10,700,024 has been obligated on UG1EY030030: $9,868,730 in federal funding and $831,294 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award